// App-Quantinova.ai

45 : Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Daniel Costin Danila

Principal Investigators

  • Aseem Anand

  • Glenn Heller

  • Mingliang Wan

  • Amrita Herkal

  • Chintan Patel

  • Raya Khanin

  • Nikolaus Schultz

  • Hans Lilja

  • Martin Fleisher

  • Howard I. Scher

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Forkhead Box A1

  • Homeobox B13

  • Kallikrein Related Peptidase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved